Drug Approval | March 09, 2024
Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility
The inspection was concluded with few procedural observations
The inspection was concluded with few procedural observations
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Subscribe To Our Newsletter & Stay Updated
